LLC:ASXLendlease Group Analysis
Data as of 2026-05-25 - not real-time
A$2.79
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Lendlease Group is trading at A$2.79, well below its 20‑day (A$3.12), 50‑day (A$3.24) and 200‑day (A$4.65) simple moving averages, with an RSI of 25 indicating oversold conditions and a bearish MACD histogram. High 30‑day volatility (≈30%) and a max drawdown of over 52% underscore a sharply deteriorating price momentum.
Fundamentally, the company posted a $318 million half‑year loss, with revenue contracting 37% year‑on‑year, negative operating and profit margins, and operating cash flow running at –A$833 million. Debt remains high at A$4.2 billion against cash of A$0.65 billion, yielding a debt‑to‑equity ratio above 75%, while ROE and ROA are both negative. Despite this, the forward P/E of 5.8 is dramatically lower than the industry average of 32.7, the price‑to‑book sits at 0.34 and the dividend yield is an elevated 8.3%, though earnings‑based sustainability is doubtful.
Given the confluence of bearish technical signals, severe earnings shortfall, and a precarious balance sheet, short‑term exposure is risky. However, the deep valuation discount and sizable asset base could present a value‑oriented upside if the restructuring and capital‑recycling initiatives bear fruit over the medium to long term.
Fundamentally, the company posted a $318 million half‑year loss, with revenue contracting 37% year‑on‑year, negative operating and profit margins, and operating cash flow running at –A$833 million. Debt remains high at A$4.2 billion against cash of A$0.65 billion, yielding a debt‑to‑equity ratio above 75%, while ROE and ROA are both negative. Despite this, the forward P/E of 5.8 is dramatically lower than the industry average of 32.7, the price‑to‑book sits at 0.34 and the dividend yield is an elevated 8.3%, though earnings‑based sustainability is doubtful.
Given the confluence of bearish technical signals, severe earnings shortfall, and a precarious balance sheet, short‑term exposure is risky. However, the deep valuation discount and sizable asset base could present a value‑oriented upside if the restructuring and capital‑recycling initiatives bear fruit over the medium to long term.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Recent $318 million loss and negative cash flow
- Bearish technical indicators (price below SMAs, MACD, RSI)
- High volatility and widening drawdown
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Significant valuation discount relative to peers
- Potential upside from capital recycling and restructuring
- Uncertain dividend sustainability amid losses
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Deep value metrics (low P/E, low P/B, high dividend yield)
- Asset‑rich business with diversified global exposure
- Potential turnaround if debt reduction and operational improvements succeed
Key Metrics & Analysis
Financial Health
Revenue Growth-37.30%
Profit Margin-2.33%
P/E Ratio5.8
ROE-2.66%
ROA-0.10%
Debt/Equity75.51
P/B Ratio0.3
Op. Cash FlowA$-833000000
Free Cash FlowA$-811124992
Industry P/E32.7
Technical Analysis
TrendBearish
RSI25.2
SupportA$2.70
ResistanceA$3.40
MA 20A$3.12
MA 50A$3.24
MA 200A$4.65
MACDBearish
VolumeIncreasing
Fear & Greed Index91.8
Valuation
Target PriceA$5.04
Upside/Downside80.75%
GradeUndervalued
TypeValue
Dividend Yield8.30%
Risk Assessment
Beta0.25
Volatility30.54%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.